US National Children's Hospital
New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity
Heidelberg University Hospital
New York Presbyterian University Hospital of Columbia and Cornell
Genetic Modification Of Immune Cells To Make Them Tireless, Cold-Blooded "Cancer Cell Killers"!
Living cell anti-aging therapy is quietly emerging